These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 526911)

  • 1. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate.
    Goldie JH; Coldman AJ
    Cancer Treat Rep; 1979; 63(11-12):1727-33. PubMed ID: 526911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative model for multiple levels of drug resistance in clinical tumors.
    Goldie JH; Coldman AJ
    Cancer Treat Rep; 1983 Oct; 67(10):923-31. PubMed ID: 6627236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facilitation of emergence of multidrug-resistant state by alteration of tumor environment: implications from competitive ecology models.
    Michelson S
    Cancer Treat Rep; 1987 Nov; 71(11):1093-4. PubMed ID: 3677116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of dose-intense chemotherapy on the development of permanent drug resistance.
    Coldman AJ; Goldie JH
    Semin Oncol; 1987 Dec; 14(4 Suppl 4):29-33. PubMed ID: 3686044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimizing drug resistance. The somatic mutation model and gestational trophoblastic neoplasia.
    Dembo AJ
    J Reprod Med; 1987 Sep; 32(9):669-74. PubMed ID: 2822921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stochastic modeling of drug resistance in cancer.
    Komarova N
    J Theor Biol; 2006 Apr; 239(3):351-66. PubMed ID: 16194548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling growth kinetics and statistical distribution of oligometastases.
    Withers HR; Lee SP
    Semin Radiat Oncol; 2006 Apr; 16(2):111-9. PubMed ID: 16564446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some drug-resistant models for cancer chemotherapy. Part 1: Cycle-nonspecific drugs.
    Usher JR; Henderson D
    IMA J Math Appl Med Biol; 1996 Jun; 13(2):99-126. PubMed ID: 8671582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrinsic versus acquired drug resistance.
    Mackillop WJ
    Cancer Treat Rep; 1986 Jun; 70(6):817-8. PubMed ID: 3731144
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of mathematical modeling in protocol formulation in cancer chemotherapy.
    Coldman AJ; Goldie JH
    Cancer Treat Rep; 1985 Oct; 69(10):1041-8. PubMed ID: 2412691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes associated with the development of resistance to imatinib (STI571) in two leukemia cell lines expressing p210 Bcr/Abl protein.
    Scappini B; Gatto S; Onida F; Ricci C; Divoky V; Wierda WG; Andreeff M; Dong L; Hayes K; Verstovsek S; Kantarjian HM; Beran M
    Cancer; 2004 Apr; 100(7):1459-71. PubMed ID: 15042680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probability of resistance evolution for exponentially growing virus in the host.
    Haeno H; Iwasa Y
    J Theor Biol; 2007 May; 246(2):323-31. PubMed ID: 17306832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of broad spectrum resistance of tumors towards anticancer drugs.
    Efferth T; Konkimalla VB; Wang YF; Sauerbrey A; Meinhardt S; Zintl F; Mattern J; Volm M
    Clin Cancer Res; 2008 Apr; 14(8):2405-12. PubMed ID: 18413831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemoresistance of tumors. Factors related to tumor kinetics and the occurrence of resistant cells].
    Tubiana M
    Bull Cancer; 1989; 76(9):959-65. PubMed ID: 2695184
    [No Abstract]   [Full Text] [Related]  

  • 15. The dynamics of cell proliferation.
    Moxnes JF; Haux J; Hausken K
    Med Hypotheses; 2004; 62(4):556-63. PubMed ID: 15050107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antitumor drug resistance and therapeutic approaches to reverse resistance].
    Tsuruo T
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1715-25. PubMed ID: 3899014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for multidrug-resistant cells in human tumor cell populations.
    Shoemaker RH; Curt GA; Carney DN
    Cancer Treat Rep; 1983 Oct; 67(10):883-8. PubMed ID: 6313186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer chemotherapy.
    Secchi GC
    Ann Ital Med Int; 1990; 5(3 Pt 3):288-95. PubMed ID: 2081089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of tumor cell chemoresistance mechanisms.
    Gatti L; Zunino F
    Methods Mol Med; 2005; 111():127-48. PubMed ID: 15911977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modes of resistance to antitumor agents.
    Kessel D
    In Vivo; 1994; 8(5):829-34. PubMed ID: 7727732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.